EXTENDED-RELEASE PHARMACEUTICAL FORMULATION COMPRISING ARIMOCLOMOL
The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof. La présente...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.
La présente invention concerne une formulation pharmaceutique qui fournit pour libération prolongée d'un ingrédient pharmaceutique actif sélectionné parmi N- [2-hydroxy -3- (1-pipéridinyle) -propoxy]-pyridine -1-oxyde -3-carboximidoyle, ses stéréoisomères et ses sels d'addition d'acide. |
|---|